Sponsor: Ncardia

Where: C22

[Show on Floor Plan]

Ncardia is a leader in contract research, development and manufacture of iPSC-based solutions for early and preclinical drug discovery. Our goal is to enable pharmaceutical and therapeutics companies to make more confident decisions in discovery and development by integrating iPSC technologies into their screening processes.
Our capabilities include disease modeling, manufacturing, assay development and high-throughput screening, with a focus on (but not limited to) cardiac and neurodegenerative diseases.

Wed5  Oct12:35pm(15 mins)	Using human iPSC technology to model disease-relevant signatures of Alzheimer's disease and other tauopathies
	Room: Auditorium 1